News & Updates
Showing Multidisciplinary articles
Showing

Canagliflozin holds promise against MAFLD in T2D patients
Patients with type 2 diabetes (T2D) who received canagliflozin benefit from improved liver biochemistry and metabolism, a recent study has shown. In addition, treatment with canagliflozin appears to confer positive effects on liver fibrosis.

DAPT after PCI: Fracture risk lower with ticagrelor vs clopidogrel in Chinese ACS patients
A territory-wide, retrospective cohort study in Hong Kong has shown that dual antiplatelet therapy (DAPT) with ticagrelor is associated with a lower risk of major osteoporotic fractures (MOF) than clopidogrel in Chinese patients with acute coronary syndrome (ACS) who underwent first-ever percutaneous coronary intervention (PCI).

High red meat consumption increases risks of CVD and diabetes
Higher consumption of both unprocessed and processed red meat is associated with higher risks of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM), according to a meta-analysis involving >4.4 million people by researchers from the University of Hong Kong (HKU).





